Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - WILLIS TOWERS WATSON PLC

19th May 2021 12:43

 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing18 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,655,840

1.28%

172,212

0.13%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

0

0.00%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

(4)

TOTAL:

 

 

 

 

1,734,299

1.34%

178,312

0.14%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

1

266.3300 USD
Purchase

1

264.0200 USD
Purchase

80

267.3200 USD
Purchase

100

267.2400 USD
Purchase

100

264.2200 USD
Purchase

104

266.9880 USD
Purchase

231

265.1755 USD
Purchase

248

267.7300 USD
Purchase

400

264.1450 USD
Purchase

476

263.6700 USD
Purchase

518

265.3950 USD
Purchase

600

264.0941 USD
Purchase

937

264.0546 USD
Purchase

1,319

264.3748 USD
Purchase

1,406

263.6732 USD
Purchase

1,780

266.2159 USD
Purchase

2,037

264.0921 USD
Purchase

2,068

267.0854 USD
Purchase

2,458

265.8989 USD
Purchase

2,679

266.5237 USD
Purchase

2,980

263.6726 USD
Purchase

3,126

264.3861 USD
Purchase

3,196

266.3756 USD
Purchase

4,595

267.0474 USD
Purchase

12,236

266.2871 USD
Purchase

12,633

264.3340 USD
Purchase

47,536

266.8931 USD
Sale

1

266.3300 USD
Sale

1

267.1600 USD
Sale

1

267.0100 USD
Sale

1

266.5400 USD
Sale

2

267.6500 USD
Sale

17

267.0900 USD
Sale

59

267.0506 USD
Sale

85

267.0600 USD
Sale

100

264.2200 USD
Sale

100

265.5240 USD
Sale

100

266.6700 USD
Sale

100

266.9800 USD
Sale

100

266.9900 USD
Sale

100

267.2100 USD
Sale

100

267.9400 USD
Sale

100

268.1900 USD
Sale

152

266.4007 USD
Sale

165

266.9000 USD
Sale

200

267.0150 USD
Sale

200

265.3750 USD
Sale

245

266.6166 USD
Sale

272

267.0257 USD
Sale

286

266.4767 USD
Sale

300

265.8466 USD
Sale

301

267.5095 USD
Sale

396

266.8227 USD
Sale

400

266.4090 USD
Sale

400

266.5000 USD
Sale

500

264.0690 USD
Sale

1,052

266.6726 USD
Sale

1,061

266.5752 USD
Sale

1,407

263.6734 USD
Sale

1,444

267.0759 USD
Sale

1,618

266.4900 USD
Sale

1,758

265.7810 USD
Sale

1,858

263.6718 USD
Sale

2,633

267.0890 USD
Sale

2,722

266.4493 USD
Sale

3,651

263.6700 USD
Sale

4,019

267.0042 USD
Sale

4,074

264.0921 USD
Sale

4,196

266.0480 USD
Sale

4,725

265.8693 USD
Sale

6,614

265.9435 USD
Sale

7,505

266.9606 USD
Sale

9,792

263.9634 USD
Sale

12,296

267.0175 USD
Sale

26,310

266.8060 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?YES
Date of disclosure:19 May 2021
Contact name:Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product nameWritten orNumber ofExerciseTypeExpiry
purchasedrelevant securitiespricedate
to which the option

 

or derivative

 

 

 

 

relates

 

 

 

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210519005481/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,992.12
Change19.48